Ameriprise Financial, Inc. (NYSE:AMP – Get Rating) announced a quarterly dividend on Wednesday, January 25th, RTT News reports. Investors of record on Friday, February 10th will be given a dividend of 1.25 per share by the financial services provider on Tuesday, February 28th. This represents a $5.00 annualized dividend and a dividend yield of 1.46%.
Ameriprise Financial has increased its dividend payment by an average of 8.6% annually over the last three years and has raised its dividend every year for the last 17 years. Ameriprise Financial has a dividend payout ratio of 15.6% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Ameriprise Financial to earn $29.36 per share next year, which means the company should continue to be able to cover its $5.00 annual dividend with an expected future payout ratio of 17.0%.
Ameriprise Financial Stock Performance
Shares of Ameriprise Financial stock traded up $2.01 during trading on Wednesday, hitting $343.01. 661,457 shares of the company’s stock traded hands, compared to its average volume of 531,485. The company has a debt-to-equity ratio of 1.60, a current ratio of 0.79 and a quick ratio of 0.79. Ameriprise Financial has a 1 year low of $219.99 and a 1 year high of $343.79. The stock has a market capitalization of $36.50 billion, a P/E ratio of 14.22, a PEG ratio of 0.67 and a beta of 1.46. The business has a 50-day simple moving average of $321.98 and a 200-day simple moving average of $290.96.
Wall Street Analysts Forecast Growth
Several research analysts have issued reports on the company. UBS Group raised their target price on Ameriprise Financial from $355.00 to $370.00 and gave the stock a “buy” rating in a research report on Monday, January 9th. Credit Suisse Group raised their target price on Ameriprise Financial to $351.00 in a research report on Tuesday, November 1st. Keefe, Bruyette & Woods cut Ameriprise Financial from an “outperform” rating to a “market perform” rating and set a $325.00 target price on the stock. in a research report on Sunday, December 18th. Piper Sandler raised their target price on Ameriprise Financial from $240.00 to $250.00 and gave the stock an “underweight” rating in a research report on Friday, October 7th. Finally, The Goldman Sachs Group lifted their price objective on Ameriprise Financial from $290.00 to $330.00 and gave the company a “neutral” rating in a research report on Wednesday, November 23rd. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Ameriprise Financial currently has a consensus rating of “Hold” and an average price target of $332.70.
Insider Buying and Selling
In other news, insider Dawn M. Brockman sold 410 shares of the business’s stock in a transaction on Tuesday, December 27th. The shares were sold at an average price of $310.63, for a total value of $127,358.30. Following the transaction, the insider now owns 875 shares of the company’s stock, valued at $271,801.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, insider Dawn M. Brockman sold 410 shares of the business’s stock in a transaction on Tuesday, December 27th. The shares were sold at an average price of $310.63, for a total value of $127,358.30. Following the transaction, the insider now owns 875 shares of the company’s stock, valued at $271,801.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO James M. Cracchiolo sold 13,050 shares of the business’s stock in a transaction on Wednesday, November 23rd. The stock was sold at an average price of $333.02, for a total transaction of $4,345,911.00. Following the completion of the transaction, the chief executive officer now directly owns 160,597 shares in the company, valued at approximately $53,482,012.94. The disclosure for this sale can be found here. In the last three months, insiders have sold 29,737 shares of company stock valued at $9,796,822. Corporate insiders own 1.00% of the company’s stock.
Institutional Investors Weigh In On Ameriprise Financial
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Brown Brothers Harriman & Co. grew its holdings in Ameriprise Financial by 106.6% during the 1st quarter. Brown Brothers Harriman & Co. now owns 126 shares of the financial services provider’s stock worth $38,000 after acquiring an additional 65 shares in the last quarter. Fairfield Bush & CO. bought a new stake in shares of Ameriprise Financial in the 1st quarter valued at about $53,000. Industrial Alliance Investment Management Inc. boosted its holdings in shares of Ameriprise Financial by 21.4% in the 1st quarter. Industrial Alliance Investment Management Inc. now owns 272 shares of the financial services provider’s stock valued at $82,000 after buying an additional 48 shares in the last quarter. Parkside Financial Bank & Trust boosted its holdings in shares of Ameriprise Financial by 43.7% in the 1st quarter. Parkside Financial Bank & Trust now owns 375 shares of the financial services provider’s stock valued at $112,000 after buying an additional 114 shares in the last quarter. Finally, qPULA Trading Management LP bought a new stake in shares of Ameriprise Financial in the 1st quarter valued at about $205,000. Hedge funds and other institutional investors own 81.66% of the company’s stock.
Ameriprise Financial Company Profile
Ameriprise Financial, Inc operates as a holding company. The firm provides financial planning, asset management and insurance services to individuals, businesses and institutions. It operates through the following business segments: Advice & Wealth Management, Asset Management, Retirement & Protection Solutions, and Corporate & Other.
Read More
- Get a free copy of the StockNews.com research report on Ameriprise Financial (AMP)
- Is The Bottom In For Cyber-Security Stocks?
- Union Pacific, Norfolk Southern Pull into Buying Zone
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Receive News & Ratings for Ameriprise Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ameriprise Financial and related companies with MarketBeat.com's FREE daily email newsletter.